Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.

www.sanofi.com

List of articles in category Sanofi
Title	Published Date
Sanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply demands	26 April 2021
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate	19 March 2021
Sanofi to provide manufacturing support to Johnson & Johnson for their COVID-19 vaccine to help address global supply demands	23 February 2021
Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine to help address public health needs	27 January 2021
Sanofi offers to acquire Kiadis for €308 million	05 November 2020
Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine	28 October 2020
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies	16 October 2020
Sanofi and GSK will provide up to 300 million doses of COVID-19 vaccine to the European Union	18 September 2020
Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate	03 September 2020
Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.	01 September 2020
Sanofi to acquire Principia Biopharma	18 August 2020
Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients	10 July 2020
Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas	24 June 2020
Sanofi invests to make France its world class center of excellence in vaccine research and production	17 June 2020
Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration	26 May 2020
Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries	14 April 2020
First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19	02 April 2020
Sanofi completes acquisition of Synthorx, Inc.	29 January 2020
Educational campaign helps teens and their caregivers tackle the everyday challenges of living with moderate-to-severe atopic dermatitis	18 September 2019
Sanofi and Google to develop new healthcare Innovation Lab	27 June 2019

Page 1 of 4